Cargando…

Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region

The interplay between dopamine and α-synuclein (AS) plays a central role in Parkinson's disease (PD). PD results primarily from a severe and selective devastation of dopaminergic neurons in substantia nigra pars compacta. The neuropathological hallmark of the disease is the presence of intraneu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrera, Fernando E., Chesi, Alessandra, Paleologou, Katerina E., Schmid, Adrian, Munoz, Adriana, Vendruscolo, Michele, Gustincich, Stefano, Lashuel, Hilal A., Carloni, Paolo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566601/ https://www.ncbi.nlm.nih.gov/pubmed/18852892 http://dx.doi.org/10.1371/journal.pone.0003394

Ejemplares similares

A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity
por: Kumar, Senthil T., et al.
Publicado: (2022)

Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs
por: Latawiec, Diane, et al.
Publicado: (2010)

The N-Terminal Residues 43 to 60 Form the Interface for Dopamine Mediated α-Synuclein Dimerisation
por: Leong, Su Ling, et al.
Publicado: (2015)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

O-GlcNAc modification forces the formation of an α-Synuclein amyloid-strain with notably diminished seeding activity and pathology
por: Balana, Aaron T., et al.
Publicado: (2023)

A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research
por: Kumar, Senthil T., et al.
Publicado: (2020)

Interaction and Redox Chemistry between Iron, Dopamine, and Alpha-Synuclein C-Terminal Peptides
por: Schifano, Fabio, et al.
Publicado: (2023)

Pronounced α-Synuclein Pathology in a Seeding-Based Mouse Model Is Not Sufficient to Induce Mitochondrial Respiration Deficits in the Striatum and Amygdala
por: Burtscher, Johannes, et al.
Publicado: (2020)

Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA
por: Bétemps, Dominique, et al.
Publicado: (2014)

The conserved C-terminal residues of FAM83H are required for the recruitment of casein kinase 1 to the keratin cytoskeleton
por: Kuga, Takahisa, et al.
Publicado: (2022)

Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
por: Chen, Yun-Hsiang, et al.
Publicado: (2021)

Ectopic Expression of AeNAC83, a NAC Transcription Factor from Abelmoschus esculentus, Inhibits Growth and Confers Tolerance to Salt Stress in Arabidopsis
por: Zhao, Xuan, et al.
Publicado: (2022)

Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein
por: Ulamec, Sabine M., et al.
Publicado: (2022)

Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils
por: Ruggeri, Francesco Simone, et al.
Publicado: (2018)

Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein
por: Izawa, Yasutaka, et al.
Publicado: (2012)

The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State
por: Runfola, Matteo, et al.
Publicado: (2020)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

The differential solvent exposure of N-terminal residues provides “fingerprints” of alpha-synuclein fibrillar polymorphs
por: Landureau, Maud, et al.
Publicado: (2021)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
por: Altay, Melek Firat, et al.
Publicado: (2022)

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease
por: Oueslati, Abid, et al.
Publicado: (2015)

GhNAC83 inhibits corm dormancy release by regulating ABA signaling and cytokinin biosynthesis in Gladiolus hybridus
por: Wu, Jian, et al.
Publicado: (2019)

A Molotov cocktail: dopamine and α-synuclein
por: Tuma, Rabiya
Publicado: (2002)

Dopamine-Induced Conformational Changes in Alpha-Synuclein
por: Outeiro, Tiago F., et al.
Publicado: (2009)

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model
por: Khandelwal, Preeti J, et al.
Publicado: (2010)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Macdonald, Jennifer A., et al.
Publicado: (2021)

Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts
por: Ardah, Mustafa T., et al.
Publicado: (2020)

Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
por: Ardah, Mustafa T., et al.
Publicado: (2014)

Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson’s disease in vivo
por: Straumann, Nadja, et al.
Publicado: (2023)

Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
por: Frey, Bryan, et al.
Publicado: (2020)

O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
por: Wani, Willayat Y., et al.
Publicado: (2017)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

O-GlcNAc modification blocks the aggregation and toxicity of the Parkinson’s disease associated protein α-synuclein
por: Marotta, Nicholas P., et al.
Publicado: (2015)

Dopamine-Mediated Oxidation of Methionine 127 in α-Synuclein Causes Cytotoxicity and Oligomerization of α-Synuclein
por: Nakaso, Kazuhiro, et al.
Publicado: (2013)

Distinct Role of Dopamine in the PFC and NAc During Exposure to Cocaine-Associated Cues
por: Kawahara, Yukie, et al.
Publicado: (2021)

Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
por: Aasly, Jan O., et al.
Publicado: (2014)

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
por: Mahul-Mellier, Anne-Laure, et al.
Publicado: (2020)

Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms
por: Petricca, Lara, et al.
Publicado: (2022)

Dopamine and α-synuclein dysfunction in Smad3 null mice
por: Tapia-González, Silvia, et al.
Publicado: (2011)

Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States
por: Illes-Toth, Eva, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fcd3o0r2qb3ctioird78ia28i1